Previous 10 | Next 10 |
home / stock / bhc:cc / bhc:cc news
2024-02-21 13:11:49 ET More on Emergent Biosolutions Emergent BioSolutions: Q3 Numbers Leave Work To Be Done Emergent BioSolutions extends shelf life of Narcan to 4 years Emergent BioSolutions wins $235.8M DoD contract Seeking Alpha’s Quant Rating on E...
2024-02-21 11:33:14 ET More on Bausch Health Companies Bausch Health: $20bn Debt Is A Mighty Elephant In The Room Bausch + Lomb draws double downgrade at J.P. Morgan on spinoff concerns Bausch gets Chinese approval for Thermage FLX and TR-4 return pad Seeking...
2024-02-21 10:14:39 ET More on Bausch + Lomb Bausch + Lomb Corporation 2023 Q4 - Results - Earnings Call Presentation Hovering Around 52-Week Low, Bausch + Lomb May Be Poised For A Rebound Bausch + Lomb Q4 2023 Earnings Preview Eminence Capital adds Sea, AMD ...
Salix to Provide Scholarships to 10 Students Living with GI Diseases LAVAL, QC / ACCESSWIRE / February 12, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced the opening of the 2024 Salix Gastrointestinal Health Scholars Program application period. The program will award...
2024-02-01 16:50:00 ET Investors are looking for a way to make back what they may have lost over the last few months. And I completely understand. But this can lead some to make some risky decisions — ones that could make things worse instead of better. That’s why right no...
LAVAL, QC / ACCESSWIRE / February 1, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced, as part of its ongoing commitment to board refreshment and board diversity, its nomination of two independent and diverse candidates to stand for election to its Board of Directors at th...
2024-02-01 16:00:00 ET With markets nearing all-time highs in the U.S. and continuing to chug higher in Canada, investors don’t seem to be too worried right now. Long-duration assets are climbing as expectations of rate cuts are factored into valuation models. Accordingly, everything...
LAVAL, QC / ACCESSWIRE / February 1, 2024 / Bausch Health Companies Inc. (NYSE/TSX:BHC) will release fourth-quarter and full-year 2023 financial results on Thursday, Feb. 22, 2024. Bausch Health will host a conference call and live webcast at 8:00 a.m. U.S. EST to discuss the results and provide...
LAVAL, QC / ACCESSWIRE / January 30, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its dermatology business, Ortho Dermatologics, today announced the U.S. launch of CABTREO™ (clindamycin, adapalene, benzoyl peroxide) Topical Gel, 1.2%/0.15%/3.1% indicated for the topical tre...
2024-01-26 08:51:01 ET More on Bausch + Lomb Bausch + Lomb: Not A Good Time To Buy (Rating Downgrade) Bausch + Lomb Corporation (BLCO) Q3 2023 Earnings Call Transcript Bausch + Lomb drops amid comments at JPMorgan Healthcare Conference Bausch + Lomb wins FDA ...
News, Short Squeeze, Breakout and More Instantly...
Bausch Health Companies Inc. Company Name:
BHC:CC Stock Symbol:
TSXC Market:
Bausch Health Companies Inc. Website:
LAVAL, QC / ACCESSWIRE / July 11, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release second quarter 2024 financial results on Thursday, August 1, 2024. Bausch Health will host a conference call and live webcast at 8:00 a.m. U.S. EST to discuss the results and provide a business...
The S&P 500 rose to a new high on Friday, putting the broad-market index on track for yet another weekly gain during the holiday-shortened trading week. The tech-heavy NASDAQ Composite also hit a new high. The Dow Jones Industrials climbed 67.87 points to end Friday at 39,375.87. The ...
2024-06-24 10:24:32 ET Investors are on the precipice of greatness these days. While we aren’t in a bull market yet, we are so close . And that makes it the perfect time to get in on some amazing stocks due to recover and rebound with massive returns. In fact, one might call ...